nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARA—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000595	0.00206	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—HSPA1A—pancreatic cancer	0.000591	0.00205	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000588	0.00204	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000588	0.00204	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NR5A2—pancreatic cancer	0.00058	0.00201	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000565	0.00196	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000564	0.00195	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000564	0.00195	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000558	0.00193	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—pancreatic cancer	0.000545	0.00189	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000541	0.00188	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000541	0.00187	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00054	0.00187	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR5A2—pancreatic cancer	0.000531	0.00184	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR5A2—pancreatic cancer	0.00052	0.0018	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000518	0.0018	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—pancreatic cancer	0.000515	0.00179	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000514	0.00178	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00051	0.00177	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NR5A2—pancreatic cancer	0.000508	0.00176	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ACVR1B—pancreatic cancer	0.000508	0.00176	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000505	0.00175	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.0005	0.00173	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR5A2—pancreatic cancer	0.000499	0.00173	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR5A2—pancreatic cancer	0.000499	0.00173	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CTNNB1—pancreatic cancer	0.000485	0.00168	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00048	0.00166	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00048	0.00166	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000468	0.00162	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—pancreatic cancer	0.000467	0.00162	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PDX1—pancreatic cancer	0.00046	0.00159	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.000458	0.00159	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—STAT3—pancreatic cancer	0.000449	0.00156	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000433	0.0015	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—STAT3—pancreatic cancer	0.000422	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—HIF1A—pancreatic cancer	0.000422	0.00146	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.00042	0.00146	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TGFB1—pancreatic cancer	0.000416	0.00144	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000415	0.00144	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—PPARG—pancreatic cancer	0.00041	0.00142	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—pancreatic cancer	0.000406	0.00141	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	0.000401	0.00139	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000398	0.00138	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TGFB1—pancreatic cancer	0.000392	0.00136	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000391	0.00136	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—pancreatic cancer	0.000389	0.00135	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000385	0.00133	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000384	0.00133	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000379	0.00131	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000377	0.00131	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—pancreatic cancer	0.000375	0.0013	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000375	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRP1—pancreatic cancer	0.000375	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000372	0.00129	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000372	0.00129	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.00037	0.00128	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—pancreatic cancer	0.000366	0.00127	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000362	0.00125	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000361	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000361	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.00036	0.00125	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—PPARG—pancreatic cancer	0.000359	0.00124	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000356	0.00123	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000347	0.0012	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—RB1—pancreatic cancer	0.000343	0.00119	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000336	0.00116	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MEN1—pancreatic cancer	0.000333	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—pancreatic cancer	0.000331	0.00115	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000327	0.00113	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000322	0.00112	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH4—pancreatic cancer	0.000316	0.00109	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000314	0.00109	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CHD3—pancreatic cancer	0.00031	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatic cancer	0.00031	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00031	0.00107	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.00031	0.00107	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MEN1—pancreatic cancer	0.000305	0.00106	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HSPA1B—pancreatic cancer	0.000301	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000301	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.0003	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MEN1—pancreatic cancer	0.000299	0.00104	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000294	0.00102	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000294	0.00102	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000292	0.00101	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SLC2A2—pancreatic cancer	0.00029	0.001	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—pancreatic cancer	0.00029	0.001	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH4—pancreatic cancer	0.000289	0.001	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000288	0.000999	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000288	0.000997	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MEN1—pancreatic cancer	0.000287	0.000992	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MEN1—pancreatic cancer	0.000287	0.000992	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH4—pancreatic cancer	0.000283	0.000981	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000283	0.000981	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000282	0.000977	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000282	0.000977	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.00028	0.000971	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000278	0.000963	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000278	0.000962	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000277	0.000958	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HSPA1B—pancreatic cancer	0.000276	0.000955	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IAPP—pancreatic cancer	0.000275	0.000953	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EZH2—pancreatic cancer	0.000274	0.00095	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH4—pancreatic cancer	0.000272	0.000941	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH4—pancreatic cancer	0.000272	0.000941	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HSPA1B—pancreatic cancer	0.00027	0.000936	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00027	0.000936	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000269	0.000931	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH3—pancreatic cancer	0.000269	0.00093	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000267	0.000926	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000267	0.000923	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000266	0.000922	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000266	0.000922	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000262	0.000908	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR5A2—pancreatic cancer	0.00026	0.000901	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HSPA1B—pancreatic cancer	0.000259	0.000898	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HSPA1B—pancreatic cancer	0.000259	0.000898	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000255	0.000885	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HSPA1A—pancreatic cancer	0.000254	0.000881	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—pancreatic cancer	0.000253	0.000875	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000251	0.000871	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000251	0.000871	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EZH2—pancreatic cancer	0.000251	0.000869	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00025	0.000866	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000247	0.000856	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000246	0.000853	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EZH2—pancreatic cancer	0.000246	0.000852	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH3—pancreatic cancer	0.000246	0.000851	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000245	0.000848	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH3—pancreatic cancer	0.000241	0.000834	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000237	0.000821	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EZH2—pancreatic cancer	0.000236	0.000817	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EZH2—pancreatic cancer	0.000236	0.000817	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HSPA1A—pancreatic cancer	0.000233	0.000806	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH3—pancreatic cancer	0.000231	0.0008	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH3—pancreatic cancer	0.000231	0.0008	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HSPA1A—pancreatic cancer	0.000228	0.00079	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—STAT3—pancreatic cancer	0.00022	0.000762	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HSPA1A—pancreatic cancer	0.000219	0.000758	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HSPA1A—pancreatic cancer	0.000219	0.000758	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000209	0.000723	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000207	0.000719	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TGFB1—pancreatic cancer	0.000204	0.000707	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SMAD4—pancreatic cancer	0.000202	0.000701	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PRSS1—pancreatic cancer	0.000202	0.0007	CbGpPWpGaD
Isotretinoin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000201	0.000283	CcSEcCtD
Isotretinoin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000201	0.000283	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—pancreatic cancer	0.000201	0.000283	CcSEcCtD
Isotretinoin—Neutropenia—Doxorubicin—pancreatic cancer	0.000201	0.000283	CcSEcCtD
Isotretinoin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.0002	0.000281	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.0002	0.000693	CbGpPWpGaD
Isotretinoin—Dry mouth—Docetaxel—pancreatic cancer	0.0002	0.000281	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.0002	0.000281	CcSEcCtD
Isotretinoin—Sweating—Epirubicin—pancreatic cancer	0.000199	0.000279	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000199	0.000279	CcSEcCtD
Isotretinoin—Asthenia—Gemcitabine—pancreatic cancer	0.000198	0.000279	CcSEcCtD
Isotretinoin—Haematuria—Epirubicin—pancreatic cancer	0.000198	0.000278	CcSEcCtD
Isotretinoin—Confusional state—Docetaxel—pancreatic cancer	0.000198	0.000278	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000196	0.000276	CcSEcCtD
Isotretinoin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000196	0.000276	CcSEcCtD
Isotretinoin—Oedema—Docetaxel—pancreatic cancer	0.000196	0.000276	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—pancreatic cancer	0.000196	0.000275	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—pancreatic cancer	0.000196	0.000275	CcSEcCtD
Isotretinoin—Pruritus—Gemcitabine—pancreatic cancer	0.000195	0.000275	CcSEcCtD
Isotretinoin—Infection—Docetaxel—pancreatic cancer	0.000195	0.000274	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—pancreatic cancer	0.000195	0.000274	CcSEcCtD
Isotretinoin—Sinusitis—Epirubicin—pancreatic cancer	0.000194	0.000273	CcSEcCtD
Isotretinoin—Diarrhoea—Irinotecan—pancreatic cancer	0.000194	0.000273	CcSEcCtD
Isotretinoin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000193	0.000272	CcSEcCtD
Isotretinoin—Pneumonia—Doxorubicin—pancreatic cancer	0.000193	0.000271	CcSEcCtD
Isotretinoin—Shock—Docetaxel—pancreatic cancer	0.000193	0.000271	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000193	0.000667	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Pruritus—Fluorouracil—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—pancreatic cancer	0.000192	0.00027	CcSEcCtD
Isotretinoin—Tachycardia—Docetaxel—pancreatic cancer	0.000191	0.000269	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TNF—pancreatic cancer	0.000191	0.00066	CbGpPWpGaD
Isotretinoin—Skin disorder—Docetaxel—pancreatic cancer	0.00019	0.000268	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00019	0.000267	CcSEcCtD
Isotretinoin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000189	0.000266	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—pancreatic cancer	0.000189	0.000265	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000188	0.000652	CbGpPWpGaD
Isotretinoin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000188	0.000264	CcSEcCtD
Isotretinoin—Dizziness—Irinotecan—pancreatic cancer	0.000187	0.000264	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000187	0.000649	CbGpPWpGaD
Isotretinoin—Haemoglobin—Epirubicin—pancreatic cancer	0.000187	0.000263	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—pancreatic cancer	0.000187	0.000263	CcSEcCtD
Isotretinoin—Anorexia—Docetaxel—pancreatic cancer	0.000187	0.000263	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000186	0.000262	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000186	0.000262	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—pancreatic cancer	0.000186	0.000262	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—pancreatic cancer	0.000186	0.000262	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—pancreatic cancer	0.000186	0.000644	CbGpPWpGaD
Isotretinoin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000186	0.000261	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000186	0.000643	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000185	0.00026	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMAD4—pancreatic cancer	0.000185	0.000641	CbGpPWpGaD
Isotretinoin—Pharyngitis—Epirubicin—pancreatic cancer	0.000185	0.00026	CcSEcCtD
Isotretinoin—Sweating—Doxorubicin—pancreatic cancer	0.000184	0.000258	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000184	0.000258	CcSEcCtD
Isotretinoin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000183	0.000258	CcSEcCtD
Isotretinoin—Hypotension—Docetaxel—pancreatic cancer	0.000183	0.000257	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—pancreatic cancer	0.000183	0.000257	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—pancreatic cancer	0.000182	0.000256	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SMAD4—pancreatic cancer	0.000181	0.000628	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000181	0.000627	CbGpPWpGaD
Isotretinoin—Epistaxis—Doxorubicin—pancreatic cancer	0.000181	0.000254	CcSEcCtD
Isotretinoin—Vomiting—Irinotecan—pancreatic cancer	0.00018	0.000253	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—pancreatic cancer	0.00018	0.000253	CcSEcCtD
Isotretinoin—Dizziness—Fluorouracil—pancreatic cancer	0.00018	0.000252	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—pancreatic cancer	0.000179	0.000252	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000179	0.000252	CcSEcCtD
Isotretinoin—Rash—Irinotecan—pancreatic cancer	0.000179	0.000251	CcSEcCtD
Isotretinoin—Dermatitis—Irinotecan—pancreatic cancer	0.000179	0.000251	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000179	0.000251	CcSEcCtD
Isotretinoin—Headache—Irinotecan—pancreatic cancer	0.000178	0.00025	CcSEcCtD
Isotretinoin—Insomnia—Docetaxel—pancreatic cancer	0.000177	0.000249	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SMAD4—pancreatic cancer	0.000177	0.000614	CbGpPWpGaD
Isotretinoin—Paraesthesia—Docetaxel—pancreatic cancer	0.000176	0.000247	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000176	0.000247	CcSEcCtD
Isotretinoin—Vomiting—Gemcitabine—pancreatic cancer	0.000176	0.000247	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ARG2—pancreatic cancer	0.000175	0.000607	CbGpPWpGaD
Isotretinoin—Dyspnoea—Docetaxel—pancreatic cancer	0.000175	0.000246	CcSEcCtD
Isotretinoin—Somnolence—Docetaxel—pancreatic cancer	0.000174	0.000245	CcSEcCtD
Isotretinoin—Rash—Gemcitabine—pancreatic cancer	0.000174	0.000245	CcSEcCtD
Isotretinoin—Dermatitis—Gemcitabine—pancreatic cancer	0.000174	0.000245	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—SMAD4—pancreatic cancer	0.000174	0.000603	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMAD4—pancreatic cancer	0.000174	0.000603	CbGpPWpGaD
Isotretinoin—Eye disorder—Epirubicin—pancreatic cancer	0.000174	0.000244	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—pancreatic cancer	0.000173	0.000244	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—HES1—pancreatic cancer	0.000173	0.000599	CbGpPWpGaD
Isotretinoin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000173	0.000243	CcSEcCtD
Isotretinoin—Headache—Gemcitabine—pancreatic cancer	0.000173	0.000243	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—pancreatic cancer	0.000173	0.000243	CcSEcCtD
Isotretinoin—Vomiting—Fluorouracil—pancreatic cancer	0.000173	0.000243	CcSEcCtD
Isotretinoin—Dyspepsia—Docetaxel—pancreatic cancer	0.000173	0.000243	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—pancreatic cancer	0.000172	0.000242	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000172	0.000242	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000171	0.000241	CcSEcCtD
Isotretinoin—Rash—Fluorouracil—pancreatic cancer	0.000171	0.000241	CcSEcCtD
Isotretinoin—Dermatitis—Fluorouracil—pancreatic cancer	0.000171	0.00024	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000171	0.00024	CcSEcCtD
Isotretinoin—Decreased appetite—Docetaxel—pancreatic cancer	0.00017	0.00024	CcSEcCtD
Isotretinoin—Headache—Fluorouracil—pancreatic cancer	0.00017	0.000239	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00017	0.000239	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00017	0.000238	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000169	0.000238	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—pancreatic cancer	0.000169	0.000238	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—pancreatic cancer	0.000169	0.000237	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000169	0.000237	CcSEcCtD
Isotretinoin—Nausea—Irinotecan—pancreatic cancer	0.000168	0.000237	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000168	0.000581	CbGpPWpGaD
Isotretinoin—Constipation—Docetaxel—pancreatic cancer	0.000168	0.000236	CcSEcCtD
Isotretinoin—Pain—Docetaxel—pancreatic cancer	0.000168	0.000236	CcSEcCtD
Isotretinoin—Chills—Epirubicin—pancreatic cancer	0.000167	0.000235	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000167	0.000577	CbGpPWpGaD
Isotretinoin—Arrhythmia—Epirubicin—pancreatic cancer	0.000166	0.000234	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—pancreatic cancer	0.000166	0.000233	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—pancreatic cancer	0.000164	0.000231	CcSEcCtD
Isotretinoin—Nausea—Gemcitabine—pancreatic cancer	0.000164	0.000231	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000163	0.000566	CbGpPWpGaD
Isotretinoin—Mental disorder—Epirubicin—pancreatic cancer	0.000163	0.000229	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000163	0.000229	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—pancreatic cancer	0.000162	0.000228	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—pancreatic cancer	0.000162	0.000228	CcSEcCtD
Isotretinoin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000162	0.000227	CcSEcCtD
Isotretinoin—Nausea—Fluorouracil—pancreatic cancer	0.000161	0.000227	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—pancreatic cancer	0.000161	0.000226	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—pancreatic cancer	0.000161	0.000226	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00016	0.000225	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—pancreatic cancer	0.00016	0.000225	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—pancreatic cancer	0.00016	0.000224	CcSEcCtD
Isotretinoin—Tension—Epirubicin—pancreatic cancer	0.000159	0.000223	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—pancreatic cancer	0.000157	0.000221	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—pancreatic cancer	0.000157	0.00022	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—pancreatic cancer	0.000156	0.00022	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—pancreatic cancer	0.000155	0.000218	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—pancreatic cancer	0.000155	0.000218	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—pancreatic cancer	0.000154	0.000217	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000154	0.000216	CcSEcCtD
Isotretinoin—RXRA—Metabolism—TYMP—pancreatic cancer	0.000153	0.000531	CbGpPWpGaD
Isotretinoin—Vision blurred—Epirubicin—pancreatic cancer	0.000153	0.000215	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000152	0.000528	CbGpPWpGaD
Isotretinoin—Alopecia—Doxorubicin—pancreatic cancer	0.000152	0.000214	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—pancreatic cancer	0.000151	0.000212	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.00015	0.000521	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00015	0.000211	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.00015	0.000519	CbGpPWpGaD
Isotretinoin—Malnutrition—Doxorubicin—pancreatic cancer	0.00015	0.000211	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—pancreatic cancer	0.00015	0.000211	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—pancreatic cancer	0.00015	0.00021	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000149	0.000518	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MEN1—pancreatic cancer	0.000149	0.000517	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH1—pancreatic cancer	0.000149	0.000516	CbGpPWpGaD
Isotretinoin—Agitation—Epirubicin—pancreatic cancer	0.000149	0.000209	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—pancreatic cancer	0.000148	0.000208	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—pancreatic cancer	0.000147	0.000207	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000147	0.000509	CbGpPWpGaD
Isotretinoin—Malaise—Epirubicin—pancreatic cancer	0.000146	0.000205	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—pancreatic cancer	0.000146	0.000205	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—pancreatic cancer	0.000145	0.000204	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—pancreatic cancer	0.000145	0.000204	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000144	0.000203	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—pancreatic cancer	0.000143	0.000496	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000143	0.000496	CbGpPWpGaD
Isotretinoin—Palpitations—Epirubicin—pancreatic cancer	0.000143	0.000201	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000142	0.0002	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NOTCH4—pancreatic cancer	0.000142	0.00049	CbGpPWpGaD
Isotretinoin—Cough—Epirubicin—pancreatic cancer	0.000141	0.000199	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—pancreatic cancer	0.000141	0.000199	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPARG—pancreatic cancer	0.000141	0.000487	CbGpPWpGaD
Isotretinoin—Asthenia—Docetaxel—pancreatic cancer	0.000141	0.000198	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—pancreatic cancer	0.00014	0.000197	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.00014	0.000485	CbGpPWpGaD
Isotretinoin—Hypertension—Epirubicin—pancreatic cancer	0.00014	0.000197	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000139	0.000196	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000139	0.000481	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000139	0.000481	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—pancreatic cancer	0.000139	0.00048	CbGpPWpGaD
Isotretinoin—Pruritus—Docetaxel—pancreatic cancer	0.000139	0.000195	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—pancreatic cancer	0.000139	0.000195	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—pancreatic cancer	0.000138	0.000194	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—pancreatic cancer	0.000138	0.000194	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—pancreatic cancer	0.000138	0.000194	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—pancreatic cancer	0.000138	0.000194	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—pancreatic cancer	0.000137	0.000193	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000137	0.000193	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NOTCH1—pancreatic cancer	0.000136	0.000472	CbGpPWpGaD
Isotretinoin—Discomfort—Epirubicin—pancreatic cancer	0.000136	0.000192	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—pancreatic cancer	0.000136	0.00047	CbGpPWpGaD
Isotretinoin—Malaise—Doxorubicin—pancreatic cancer	0.000135	0.00019	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HSPA1B—pancreatic cancer	0.000135	0.000468	CbGpPWpGaD
Isotretinoin—Dry mouth—Epirubicin—pancreatic cancer	0.000135	0.00019	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—pancreatic cancer	0.000134	0.000189	CcSEcCtD
Isotretinoin—Diarrhoea—Docetaxel—pancreatic cancer	0.000134	0.000189	CcSEcCtD
Isotretinoin—RARB—Gene Expression—NOTCH1—pancreatic cancer	0.000134	0.000463	CbGpPWpGaD
Isotretinoin—Confusional state—Epirubicin—pancreatic cancer	0.000133	0.000187	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—pancreatic cancer	0.000132	0.000186	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—pancreatic cancer	0.000132	0.000186	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000132	0.000186	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000132	0.000185	CcSEcCtD
Isotretinoin—Infection—Epirubicin—pancreatic cancer	0.000131	0.000185	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000131	0.000454	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—pancreatic cancer	0.000131	0.000184	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—NOTCH1—pancreatic cancer	0.000131	0.000453	CbGpPWpGaD
Isotretinoin—Shock—Epirubicin—pancreatic cancer	0.00013	0.000183	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—pancreatic cancer	0.00013	0.000183	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—pancreatic cancer	0.00013	0.000182	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—pancreatic cancer	0.00013	0.000182	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000129	0.000182	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—pancreatic cancer	0.000129	0.000182	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—pancreatic cancer	0.000129	0.000181	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—PPARG—pancreatic cancer	0.000129	0.000446	CbGpPWpGaD
Isotretinoin—Skin disorder—Epirubicin—pancreatic cancer	0.000128	0.000181	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NOTCH1—pancreatic cancer	0.000128	0.000444	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH1—pancreatic cancer	0.000128	0.000444	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000128	0.00018	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000128	0.000442	CbGpPWpGaD
Isotretinoin—Myalgia—Doxorubicin—pancreatic cancer	0.000128	0.000179	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—pancreatic cancer	0.000128	0.000179	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—pancreatic cancer	0.000128	0.000179	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—pancreatic cancer	0.000127	0.000179	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000127	0.000178	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000126	0.000438	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PPARG—pancreatic cancer	0.000126	0.000437	CbGpPWpGaD
Isotretinoin—Discomfort—Doxorubicin—pancreatic cancer	0.000126	0.000177	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—pancreatic cancer	0.000126	0.000177	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—pancreatic cancer	0.000125	0.000175	CcSEcCtD
Isotretinoin—Vomiting—Docetaxel—pancreatic cancer	0.000125	0.000175	CcSEcCtD
Isotretinoin—Rash—Docetaxel—pancreatic cancer	0.000124	0.000174	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—pancreatic cancer	0.000124	0.000174	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GLP1R—pancreatic cancer	0.000123	0.000428	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000123	0.000428	CbGpPWpGaD
Isotretinoin—Dermatitis—Docetaxel—pancreatic cancer	0.000123	0.000174	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—pancreatic cancer	0.000123	0.000173	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—PPARG—pancreatic cancer	0.000123	0.000427	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EZH2—pancreatic cancer	0.000123	0.000426	CbGpPWpGaD
Isotretinoin—Headache—Docetaxel—pancreatic cancer	0.000123	0.000173	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000122	0.000172	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—pancreatic cancer	0.000122	0.000172	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—pancreatic cancer	0.000122	0.000171	CcSEcCtD
Isotretinoin—RXRA—Metabolism—DPYD—pancreatic cancer	0.000121	0.000421	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPARG—pancreatic cancer	0.000121	0.000419	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPARG—pancreatic cancer	0.000121	0.000419	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00012	0.000169	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NOTCH3—pancreatic cancer	0.00012	0.000417	CbGpPWpGaD
Isotretinoin—Shock—Doxorubicin—pancreatic cancer	0.00012	0.000169	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00012	0.000169	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00012	0.000168	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—pancreatic cancer	0.00012	0.000168	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—pancreatic cancer	0.000119	0.000168	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—pancreatic cancer	0.000119	0.000167	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—pancreatic cancer	0.000119	0.000167	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000118	0.000166	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—pancreatic cancer	0.000118	0.000166	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—pancreatic cancer	0.000118	0.000165	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—pancreatic cancer	0.000117	0.000164	CcSEcCtD
Isotretinoin—Nausea—Docetaxel—pancreatic cancer	0.000116	0.000164	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—pancreatic cancer	0.000116	0.000164	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC2A2—pancreatic cancer	0.000115	0.000399	CbGpPWpGaD
Isotretinoin—Decreased appetite—Epirubicin—pancreatic cancer	0.000115	0.000162	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—pancreatic cancer	0.000114	0.000161	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000114	0.00016	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000114	0.000395	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HSPA1A—pancreatic cancer	0.000114	0.000395	CbGpPWpGaD
Isotretinoin—Fatigue—Epirubicin—pancreatic cancer	0.000114	0.00016	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MMP2—pancreatic cancer	0.000113	0.000392	CbGpPWpGaD
Isotretinoin—Pain—Epirubicin—pancreatic cancer	0.000113	0.000159	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—pancreatic cancer	0.000113	0.000159	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000111	0.000157	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000156	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00011	0.000381	CbGpPWpGaD
Isotretinoin—Paraesthesia—Doxorubicin—pancreatic cancer	0.00011	0.000154	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000109	0.000153	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000109	0.000153	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—pancreatic cancer	0.000109	0.000153	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000108	0.000152	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.000151	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000106	0.000149	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000106	0.000148	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—pancreatic cancer	0.000105	0.000148	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—pancreatic cancer	0.000105	0.000148	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—pancreatic cancer	0.000105	0.000147	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—pancreatic cancer	0.000105	0.000147	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—pancreatic cancer	0.000105	0.000147	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—pancreatic cancer	0.000105	0.000147	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000104	0.000361	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000142	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.0001	0.000347	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.0001	0.000141	CcSEcCtD
Isotretinoin—Hypersensitivity—Epirubicin—pancreatic cancer	9.74e-05	0.000137	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—pancreatic cancer	9.72e-05	0.000137	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—pancreatic cancer	9.67e-05	0.000136	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—pancreatic cancer	9.67e-05	0.000136	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—pancreatic cancer	9.48e-05	0.000133	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—pancreatic cancer	9.35e-05	0.000131	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—SMAD4—pancreatic cancer	9.07e-05	0.000314	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—pancreatic cancer	9.04e-05	0.000127	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—pancreatic cancer	9.01e-05	0.000127	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CD44—pancreatic cancer	8.93e-05	0.000309	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—pancreatic cancer	8.78e-05	0.000123	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.74e-05	0.000303	CbGpPWpGaD
Isotretinoin—Dizziness—Epirubicin—pancreatic cancer	8.74e-05	0.000123	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—pancreatic cancer	8.68e-05	0.000301	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.66e-05	0.0003	CbGpPWpGaD
Isotretinoin—Pruritus—Doxorubicin—pancreatic cancer	8.65e-05	0.000122	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GCG—pancreatic cancer	8.56e-05	0.000296	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—pancreatic cancer	8.51e-05	0.000295	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—pancreatic cancer	8.41e-05	0.000118	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—pancreatic cancer	8.37e-05	0.000118	CcSEcCtD
Isotretinoin—Rash—Epirubicin—pancreatic cancer	8.34e-05	0.000117	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—pancreatic cancer	8.33e-05	0.000117	CcSEcCtD
Isotretinoin—Headache—Epirubicin—pancreatic cancer	8.28e-05	0.000116	CcSEcCtD
Isotretinoin—Dizziness—Doxorubicin—pancreatic cancer	8.09e-05	0.000114	CcSEcCtD
Isotretinoin—RXRA—Metabolism—STK11—pancreatic cancer	8.05e-05	0.000279	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—pancreatic cancer	8.02e-05	0.000278	CbGpPWpGaD
Isotretinoin—Nausea—Epirubicin—pancreatic cancer	7.85e-05	0.00011	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SRC—pancreatic cancer	7.84e-05	0.000272	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—pancreatic cancer	7.78e-05	0.000109	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—pancreatic cancer	7.71e-05	0.000108	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—pancreatic cancer	7.71e-05	0.000108	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—pancreatic cancer	7.66e-05	0.000108	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—VEGFA—pancreatic cancer	7.64e-05	0.000265	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—STAT3—pancreatic cancer	7.57e-05	0.000262	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.55e-05	0.000262	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—pancreatic cancer	7.55e-05	0.000261	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—pancreatic cancer	7.47e-05	0.000259	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—pancreatic cancer	7.34e-05	0.000254	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—pancreatic cancer	7.27e-05	0.000102	CcSEcCtD
Isotretinoin—RARB—Gene Expression—MYC—pancreatic cancer	7.2e-05	0.000249	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—pancreatic cancer	7.01e-05	0.000243	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—pancreatic cancer	6.92e-05	0.00024	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—pancreatic cancer	6.9e-05	0.000239	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—pancreatic cancer	6.9e-05	0.000239	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—pancreatic cancer	6.88e-05	0.000238	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH1—pancreatic cancer	6.68e-05	0.000231	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—pancreatic cancer	6.55e-05	0.000227	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—pancreatic cancer	6.5e-05	0.000225	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARG—pancreatic cancer	6.31e-05	0.000218	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—APOE—pancreatic cancer	5.63e-05	0.000195	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—pancreatic cancer	5.56e-05	0.000193	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—pancreatic cancer	5.52e-05	0.000191	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.33e-05	0.000185	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—pancreatic cancer	5.09e-05	0.000176	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—pancreatic cancer	5.08e-05	0.000176	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—pancreatic cancer	4.99e-05	0.000173	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARG—pancreatic cancer	4.9e-05	0.00017	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—pancreatic cancer	4.88e-05	0.000169	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—pancreatic cancer	4.78e-05	0.000166	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—pancreatic cancer	4.78e-05	0.000166	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CD—pancreatic cancer	4.47e-05	0.000155	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CB—pancreatic cancer	3.89e-05	0.000135	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—pancreatic cancer	3.86e-05	0.000134	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—pancreatic cancer	3.6e-05	0.000125	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—pancreatic cancer	3.36e-05	0.000117	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—pancreatic cancer	2.49e-05	8.64e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—pancreatic cancer	2.37e-05	8.22e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—pancreatic cancer	1.94e-05	6.72e-05	CbGpPWpGaD
